Michaela Portmann
Papers
1
Total Citations
32
H-Index
1
About
Michaela Portmann is a rising figure in nanomedicine, whose work focuses on the rational design of lipid nanoparticle (LNP) formulations for drug and gene delivery. Her research bridges materials science and pharmaceutics, with a particular emphasis on understanding how the chemical structure of non-ionizable lipids and the methods used to mix phases influence the structural integrity and performance of LNPs. In her highly cited 2023 paper, "Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations," Portmann provides critical insights into how subtle changes in lipid composition and processing can dramatically alter nanoparticle morphology, stability, and encapsulation efficiency. This work, which has already garnered over 30 citations, is foundational for researchers aiming to optimize LNPs for mRNA vaccines and therapeutic delivery. By systematically deconstructing the interplay between lipid chemistry and manufacturing parameters, Portmann has established a framework for more predictable and scalable nanoparticle engineering. Her contributions are particularly timely, given the central role of LNPs in modern vaccinology and gene therapy. As her citation record grows, Portmann is cementing her reputation as a key innovator in the next generation of lipid-based delivery systems.
Research Focus
Key Achievements
Top Papers
- 1